SCHEMBL18520131

SCHEMBL18520131

Nc1ccc(-c2cnn(C(F)F)c2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 4/20 0.44
PIK3CD O00329 2/20 0.37
PIK3CA P42336 2/20 0.37
PIK3CG P48736 2/20 0.37
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
PDE3B Q13370 2/20 0.32
PDE3A Q14432 2/20 0.32
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
TTK P33981 1/20 0.31
FGFR1 P11362 1/20 0.31
FGFR2 P21802 1/20 0.31
FGFR3 P22607 1/20 0.31
HSP90AA1 P07900 1/20 0.31
KIT P10721 2/20 0.31
EGFR P00533 1/20 0.31
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18520105 0.80 ALDH1A1 (0.41) ALOX5APPIK3CDPIK3CAPIK3CGPDE3B
SCHEMBL3386265 0.75 CYP11B1 (0.49) ALOX5APPIM1CYP11B1CYP11B2FGFR3
SCHEMBL29640802 0.75 CYP11B1 (0.49) ALOX5APPIM1CYP11B1CYP11B2FGFR3
SCHEMBL28511565 0.72 PIK3CD (0.44) ALOX5APPIK3CDPIK3CAPIK3CGPDE3B
SCHEMBL30640940 0.72 PIK3CD (0.44) ALOX5APPIK3CDPIK3CAPIK3CGPDE3B
SCHEMBL19576762 0.72 PDE3B (0.38) ALOX5APPIK3CDPIK3CAPIK3CGPDE3B
SCHEMBL3262269 0.70
SCHEMBL30337692 0.70 METAP2 (0.45) CYP11B1CYP11B2
SCHEMBL8974216 0.70 METAP2 (0.45) CYP11B1CYP11B2
SCHEMBL18519738 0.70 PIK3CD (0.45) ALOX5APPIK3CDPIK3CAPIK3CGPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017024996-A1 HYDROXY AMIDINE DERIVATIVE, PREPARATION METHOD AND USE IN MEDICINE THEREOF 江苏恒瑞医药股份有限公司 2017-02-16 WO disclosed